» Articles » PMID: 2155270

Innate Resistance to Herpes Simplex Virus Infection. Human Lymphocyte and Monocyte Inhibition of Viral Replication

Overview
Journal J Immunol
Date 1990 Mar 1
PMID 2155270
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral blood monocytes and lymphocytes isolated from most humans are resistant to HSV infection in vitro. Viral replication is inhibited very early in the cycle, prior to the onset of alpha-protein synthesis; no viral protein or DNA synthesis is detectable even up to 1 week later. The enhanced expression of two 62-kDa and 57-kDa cellular proteins, however, is induced in the lymphocyte population within 3 to 5 h after infection. A 30-kDa protein is induced in the monocyte population immediately after infection. The induced expression of 62-kDa and 57-kDa lymphocyte proteins appears to be virus-mediated because: a) HSV and pseudorabies virus (although not vaccinia virus) induce the expression of 62-kDa and 57-kDa proteins, b) heat shock or exposure of lymphocytes to uninfected cell extracts does not induce expression of either protein, c) 62-kDa protein is not induced in lymphocytes stimulated with a mitogenic concentration of PHA. UV-inactivated HSV induces expression of 62-kDa and 57-kDa proteins in a manner similar to that observed with untreated virus. In contrast, expression of 30-kDa monocyte protein is induced nonspecifically by either uninfected cell extracts or cell extracts containing virus. Sixty-two-kilodalton and 57-kDa protein induction appears to be a marker for human lymphocytes that express profound intracellular resistance to infection with HSV. Induced expression of these proteins occurs only in lymphocytes that inhibit viral replication very early in the growth cycle, prior to the onset of alpha-protein synthesis. Expression of 62-kDa and 57-kDa proteins is not induced in lymphocytes that are permissive or partially permissive to infection with HSV.

Citing Articles

Abortive Infection of Animal Cells: What Goes Wrong.

Embry A, Gammon D Annu Rev Virol. 2024; 11(1):193-213.

PMID: 38631917 PMC: 11427174. DOI: 10.1146/annurev-virology-100422-023037.


Essential role of M1 macrophages in blocking cytokine storm and pathology associated with murine HSV-1 infection.

Jaggi U, Matundan H, Yu J, Hirose S, Mueller M, Wormley Jr F PLoS Pathog. 2021; 17(10):e1009999.

PMID: 34653236 PMC: 8550391. DOI: 10.1371/journal.ppat.1009999.


Unravelling the first key steps in equine herpesvirus type 5 (EHV5) pathogenesis using ex vivo and in vitro equine models.

Van Cleemput J, Poelaert K, Laval K, Nauwynck H Vet Res. 2019; 50(1):13.

PMID: 30777128 PMC: 6380010. DOI: 10.1186/s13567-019-0630-6.


Inclusion of CD80 in HSV targets the recombinant virus to PD-L1 on DCs and allows productive infection and robust immune responses.

Mott K, Allen S, Zandian M, Akbari O, Hamrah P, Maazi H PLoS One. 2014; 9(1):e87617.

PMID: 24475315 PMC: 3903765. DOI: 10.1371/journal.pone.0087617.


Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.

Stiles K, Whitbeck J, Lou H, Cohen G, Eisenberg R, Krummenacher C J Virol. 2010; 84(22):11646-60.

PMID: 20826693 PMC: 2977867. DOI: 10.1128/JVI.01550-10.